Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
The protein encoded by IL1RL1 is a member of the interleukin 1 receptor family. De plus, nous expédions IL1RL1 Kits (32) et IL1RL1 Protéines (30) et beaucoup plus de produits pour cette protéine.
Showing 10 out of 122 products:
Human Polyclonal IL1RL1 Primary Antibody pour CyTOF, FACS - ABIN4899402
Hong, Moon, Joo, Jeon, Cho, Ju, Oh, Heo, Park, Kim, Min: Measurement of interleukin-33 (IL-33) and IL-33 receptors (sST2 and ST2L) in patients with rheumatoid arthritis. dans Journal of Korean medical science 2011
Show all 8 Pubmed References
Mouse (Murine) Monoclonal IL1RL1 Primary Antibody pour CyTOF, ELISA (Capture) - ABIN4900020
Ohno, Oboki, Morita, Kajiwara, Arae, Tanaka, Ikeda, Iikura, Akiyama, Inoue, Matsumoto, Sudo, Azuma, Okumura, Kamradt, Saito, Nakae: Paracrine IL-33 stimulation enhances lipopolysaccharide-mediated macrophage activation. dans PLoS ONE 2011
Show all 3 Pubmed References
Human Polyclonal IL1RL1 Primary Antibody pour IHC, IHC (p) - ABIN4325562
ODonnell, Mahmoud, Keane, Murphy, White, Carey, ORiordain, Bennett, Brint, Houston: An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer. dans British journal of cancer 2016
Mouse (Murine) Polyclonal IL1RL1 Primary Antibody pour WB - ABIN361230
Zhao, Ji, Wang, Gu, Song, Zhang, Liu, Chen, Zhang: Cell surface proteomics analysis indicates a neural lineage bias of rat bone marrow mesenchymal stromal cells. dans BioMed research international 2014
Taken together, our data provide the evidence that ST2 deficiency in early phase of sepsis downregulates myeloid precursors, inflammatory NK and dendritic cells
Studied the association of interleukin 1 receptor-like 1 deficiency (St2) on renal ischaemia-reperfusion injury in euglycaemic and hyperglycaemic mice.
sST2 (Montrer SSTR2 Anticorps) is downregulated in high-metastatic cells compared with low-metastatic human and mouse CRC (Montrer SCRIB Anticorps) cells. Knockdown of sST2 (Montrer SSTR2 Anticorps) in low-metastatic cells enhances tumour growth, metastasis and tumour angiogenesis, whereas its overexpression in high-metastatic cells suppresses these processes.
IL-33/ST2 can induce production of proinflammatory cytokines, such as TNF-alpha and IL-6, through production of IL-13 in Plasmodium chabaudi-infected BALB/c mice, suggesting that IL-33/ST2 play a critical role in inflammatory responses to malaria infection.
these results provide new insights into the mechanisms by which intestinal epithelial cells , via IL-33/ST2 axis, may control pro-inflammatory TH17 cells in the small intestine to sustain homeostasis
Results indicate that IL-33/ST2 signaling is functionally present in primary sensory neurons and contributes to pruritus in poison ivy ACD. Blocking IL-33/ST2 signaling may represent a therapeutic approach to ameliorate itch and skin inflammation related to poison ivy allergic contact dermatitis.
CLOCK temporally gates mast cell responses to IL-33 (Montrer IL33 Anticorps) via regulation of ST2 (Montrer SULT2A1 Anticorps) expression. Our findings provide novel insights into IL-33 (Montrer IL33 Anticorps)/mast cell-associated physiology and pathologies.
an increased prevalence in neonatal mortality was observed in litters from dams lacking ST2
Taken together, the data demonstrate a critical role of MyD88 (Montrer MYD88 Anticorps) in DCs and of IL-33 (Montrer IL33 Anticorps) signaling via ST2 (Montrer SULT2A1 Anticorps) in MC903-induced Atopic dermatitis (AD). These data suggest that IL-33 (Montrer IL33 Anticorps)/IL-33R may be a therapeutic target of AD.
Heligmosomoides polygyrus Alarmin Release Inhibitor (HpARI) prevents binding of active interleukin-33 (IL-33 (Montrer IL33 Anticorps)) to the IL-33 (Montrer IL33 Anticorps) receptor.
IL33R was found induced in the blood of asthmatic children with additional gram-positive bacteria in the nasopharynx.
Higher IL-33 (Montrer IL33 Anticorps) and lower s-ST2 (Montrer SULT2A1 Anticorps) receptor baseline serum levels were detected in Pru p 3--sensitized allergic patients (SAP (Montrer APCS Anticorps)). IL-33 (Montrer IL33 Anticorps)/s-ST2 (Montrer SULT2A1 Anticorps) ratio is increased in Pru p 3-SAP (Montrer APCS Anticorps) and more in patients who experienced severe systemic symptoms.
sST2 (Montrer SSTR2 Anticorps) is downregulated in high-metastatic cells compared with low-metastatic human and mouse CRC (Montrer CALR Anticorps) cells. Knockdown of sST2 (Montrer SSTR2 Anticorps) in low-metastatic cells enhances tumour growth, metastasis and tumour angiogenesis, whereas its overexpression in high-metastatic cells suppresses these processes.
IL-33 (Montrer IL33 Anticorps) promotes Renal Cell Carcinoma (Montrer MOK Anticorps) cell proliferation and chemotherapy resistance via its receptor ST2 (Montrer SULT2A1 Anticorps) and the JNK (Montrer MAPK8 Anticorps) signaling activation in tumor cells.
sST2 (Montrer SSTR2 Anticorps) in preschool wheezers has predictive value for the development of eosinophilic airway inflammation in asthmatic children at school age.
Findings indicate that IL33 (Montrer IL33 Anticorps) may be involved in the process of glioma cell invasion and migration by upregulating MMP2 (Montrer MMP2 Anticorps) and MMP9 (Montrer MMP9 Anticorps) via the ST2 (Montrer SULT2A1 Anticorps)-NF-kappaB (Montrer NFKB1 Anticorps) signaling pathway.
is involved in Th2 inflammation including eosinophil activation. Single nucleotide polymorphisms (SNPs) of the IL1RL1 gene are associated with asthma development and increased peripheral blood eosinophil counts.
Findings indicate that IL-10 act as a negative regulator of IL-33/ST2 signaling pathways in vivo.
Foxp3 (Montrer FOXP3 Anticorps)(+) cells in the brains of Multiple sclerosis patients predominantly produce interleukin-10 (IL-10 (Montrer IL10 Anticorps)) and show high expression of the IL-33 (Montrer IL33 Anticorps) receptor ST2 (Montrer SULT2A1 Anticorps).
In patients with stable mild to moderate chronic heart failure with reduced ventricular ejection fraction, a single measurement of sST2 (Montrer SSTR2 Anticorps) protein and glucose were independent variables for hospitalization due to worsening CHF over a 1-year follow-up period.
The protein encoded by this gene is a member of the interleukin 1 receptor family. Studies of the similar gene in mouse suggested that this receptor can be induced by proinflammatory stimuli, and may be involved in the function of helper T cells. This gene, interleukin 1 receptor, type I (IL1R1), interleukin 1 receptor, type II (IL1R2) and interleukin 1 receptor-like 2 (IL1RL2) form a cytokine receptor gene cluster in a region mapped to chromosome 2q12. Alternative splicing of this gene results in multiple transcript variants.
, interleukin-1 receptor-like 1
, lymphocyte antigen 84
, protein T1
, growth stimulation-expressed
, homolog of mouse growth stimulation-expressed
, interleukin 1 receptor-related protein
, fos-responsive gene 1 protein